Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:Japan
|
| gptkbp:founded |
1946
|
| gptkbp:founder |
Yoshinori Kissei
|
| gptkbp:headquarters_location |
gptkb:Matsumoto,_Nagano,_Japan
|
| https://www.w3.org/2000/01/rdf-schema#label |
Kissei Pharmaceutical
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:Silodosin
Fostamatinib Glufosfamide Mitiglinide |
| gptkbp:numberOfEmployees |
1,500 (approximate)
|
| gptkbp:products |
pharmaceutical drugs
|
| gptkbp:servesArea |
worldwide
|
| gptkbp:stockExchange |
gptkb:Tokyo_Stock_Exchange
|
| gptkbp:stockSymbol |
4547
|
| gptkbp:type |
gptkb:public_company
|
| gptkbp:website |
https://www.kissei.co.jp
|
| gptkbp:bfsParent |
gptkb:Silodosin
|
| gptkbp:bfsLayer |
8
|